Pharmaceutical-Grade Cinitapride Immediate-Release Pellets for Oral Multiparticulate Formulations
Cinitapride IR Pellets are pharmaceutical-grade immediate-release pellets containing Cinitapride as the active ingredient. Cinitapride is a benzamide compound with the molecular formula C₂₁H₃₀N₄O₄, CAS Number 66564-14-5, and molecular weight approximately 402.5 g/mol.
The immediate-release pellet format provides a multiparticulate approach for oral formulation development. Cinitapride pellets can be incorporated into capsule-filling and other oral dosage-form manufacturing processes where an immediate-release pellet system is required.
As a Cinitapride IR Pellets Manufacturer in India, Swapnroop focuses on pharmaceutical pellet formulations with product-specific active loading, particle-size distribution and physical characteristics. Finished-product parameters should be established according to the applicable formulation and batch specification.
Cinitapride IR Pellets can be used for:
Cinitapride IR Pellets can be supplied in suitable pharmaceutical packaging according to the applicable product and batch requirements. Final active loading, particle size, moisture, density, friability and dissolution requirements should be confirmed against the current product specification.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 95.0% – 105.0% |
| Loss on Drying | NMT 0.5% |
| Residue on Ignition | NMT 0.1% |
| Individual Impurity | NMT 0.5% |
| Total Impurities | ≤ 1.5% |
| Water Content | NMT 0.5% |